Novita Pharmaceuticals' Unattributed - II Round

Novita Pharmaceuticals raised a round of funding on April 07, 2017.

Novita Pharmaceuticals is developing new drug molecules to prevent cancer metastasis by targeting a new gene target, fascin.…

Articles about Novita Pharmaceuticals' Unattributed - II Round: